Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
68.89
+2.20 (3.30%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $65.5. The average 1-year stock price forecast is 4.92% lower than the current stock price, while the lowest is $40 (-41.94%) and the highest is $97 (+40.80%).
Price Target: $65.5 (-4.92%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 11 | 12 | 12 | 11 | 11 | 11 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 15 | 16 | 17 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Barclays No rating | Barclays | Sell Initiates $65 | Sell | Initiates | $65 | -5.65% | Oct 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $60 | Hold | Maintains | $60 | -12.90% | Oct 2, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $60 → $75 | Hold | Maintains | $60 → $75 | +8.87% | Oct 1, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $80 → $85 | Buy | Maintains | $80 → $85 | +23.39% | Sep 23, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Reiterates $71 → $97 | Buy | Reiterates | $71 → $97 | +40.80% | Sep 21, 2026 |
Financial Forecast
Revenue This Year
853.86M
from 911.98M
Decreased by -6.37%
Revenue Next Year
887.20M
from 853.86M
Increased by 3.91%
EPS This Year
1.25
from 2.42
Decreased by -48.36%
EPS Next Year
1.55
from 1.25
Increased by 23.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.